Carvana's $93 Target Isn't About $1 - It's About Disappointed FOMO

Barclays' $1 cut changed the narrative, not the rating

This was not a downgrade. Barclays cut Carvana's price target by exactly $1, to $93 from $94, and kept an Overweight rating. But the move still mattered. Before the quarter, Carvana was trading like a stock that could keep surprising investors. After Q2 adjusted EBITDA came in below Barclays' expectations but slightly above Street consensus, the tone shifted from potential upside to whether the company had simply cleared the bar.

Carvana is being judged as an execution stock now

The operating results still look strong. Carvana reported LTM EBITDA of $2.34 billion and revenue up 52% to $22.5 billion. Those are not the numbers of a company losing momentum. But the market was looking for new upside levers, and investors were looking for upside levers that did not clearly show up in the release. For a high-beta stock, that can be enough to change the psychology around it.

Why a $1 cut felt bigger than the number itself

The real signal was in the guidance. Barclays said Carvana's 2026 EBITDA guidance of $2.7 billion to $3.0 billion aligned with or fell below Street forecasts. In other words, the easy rerating setup was gone. Barclays still sees upside potential to its estimates, but the burden of proof is now on management to deliver another clear catalyst.

Why sentiment can reset even when the business has not

The $1 change mattered because the stock was already vulnerable

Carvana was already coming off a 20% year-to-date decline, which makes investors more likely to read mixed news as confirmation of a worsening story. When Barclays then cut its target to $93 from $94 while keeping Overweight, the headline and the substance sent different messages. The rating stayed constructive; the lower target subtly narrowed the room for a quick rerating.

Analyst targets show disagreement, not consensus

That tension is visible in the target-price spread. Barclays is now at $93, other firms are cited around $80 and $90, and the broader market still has targets ranging widely enough to show there is no single view on how much credit to give future execution. For now, the market is pricing a tug-of-war between strong operations and weaker near-term catalysts.

What to watch in Carvana from here

The near-term test is whether management can reclaim the upside narrative. With a consensus target price of $88.30 and outside targets including $80 and $90, investors are not dealing with a clean story. That argues for patience rather than chasing the stock simply because Barclays still views it positively.

The cleanest setup still depends on fresh catalysts

Carvana still has the operating engine: LTM EBITDA was $2.34 billion, revenue rose 52% to $22.5 billion, and Barclays said Q2 adjusted EBITDA came in slightly above Street consensus. But the stock now needs proof that another leg of upside is underway, not just another solid quarter. If management lifts the forward EBITDA frame and investors still treat it as merely fine, the old FOMO story is likely over.